Your session is about to expire
← Back to Search
MyChart Proxy Outreach to Parents (MyPOP) for Health Technology (MyPOP Trial)
N/A
Waitlist Available
Led By Ada Fenick, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks
Awards & highlights
MyPOP Trial Summary
This trial will assess whether texting or portal messages can help more parents get access to their kids' medical records.
Who is the study for?
This trial is for parents or guardians of children aged 12 years or younger who have been seen at one of two health centers in the last three years. They must not already have proxy access to their child's electronic health records (EHR) and should not prefer contact by phone or physical letter.Check my eligibility
What is being tested?
The study is testing whether contacting parents through text messages, patient portal messages, or no message at all can increase their access to their children's medical records. It aims to find out which method is more effective: text messaging, portal messaging, or the usual in-office suggestions.See study design
What are the potential side effects?
Since this trial involves communication methods rather than medical treatments, there are no direct side effects like those associated with medications. However, privacy concerns regarding EHR access could be considered an indirect 'side effect'.
MyPOP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of participants who activate MyChart Proxy Access
Secondary outcome measures
Proportion of guardians' who activate a personal MyChart account
MyPOP Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Preferred ModalityExperimental Treatment2 Interventions
Text or email message to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart.
Group II: Patient PortalExperimental Treatment1 Intervention
Patient portal message (MyChart) to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart.
Group III: Usual CareActive Control1 Intervention
Care as usual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Email
2016
N/A
~38210
Text
2022
N/A
~5500
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,853 Previous Clinical Trials
2,733,361 Total Patients Enrolled
Ada Fenick, MDPrincipal InvestigatorYale University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am the guardian of a child ≤12 years old who has been seen at a specified health center in the last 3 years.I prefer to be contacted by phone or letter as I don't use MyChart.
Research Study Groups:
This trial has the following groups:- Group 1: Patient Portal
- Group 2: Usual Care
- Group 3: Preferred Modality
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this medical trial still taking place?
"Clinicaltrials.gov indicates that this research endeavour is no longer actively recruiting participants, as the most recent update was on August 10th 2023. Even though this trial has concluded recruitment of volunteers, there are still 1 other medical studies seeking individuals to join their clinical trials."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger